Current strategies for brain drug delivery

X Dong - Theranostics, 2018 - pmc.ncbi.nlm.nih.gov
The blood-brain barrier (BBB) has been a great hurdle for brain drug delivery. The BBB in
healthy brain is a diffusion barrier essential for protecting normal brain function by impeding …

Beyond the blood: brain barrier: the importance of central nervous system (CNS) pharmacokinetics for the treatment of CNS tumors, including diffuse intrinsic pontine …

KE Warren - Frontiers in oncology, 2018 - frontiersin.org
Over the past decade, we have made considerable progress in establishing diffuse intrinsic
pontine glioma (DIPG) as a disease entity and develo** preclinical tools to interrogate …

Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles

F Sousa, HK Dhaliwal, F Gattacceca… - Journal of controlled …, 2019 - Elsevier
Glioblastoma multiforme (GBM) is one of the most aggressive cancers, where the
aggressiveness of tumor has been associated to its high vascularization rate. Bevacizumab …

[HTML][HTML] Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis

P Lohmann, M Kocher, G Ceccon, EK Bauer… - NeuroImage: Clinical, 2018 - Elsevier
Background The aim of this study was to investigate the potential of combined textural
feature analysis of contrast-enhanced MRI (CE-MRI) and static O-(2-[18 F] fluoroethyl)-L …

Nanobiotechnology-based treatment strategies for malignant relapsed glioma

Q Qiu, X Ding, J Chen, S Chen, J Wang - Journal of Controlled Release, 2023 - Elsevier
Gliomas are the most aggressive and lethal tumors of the central nervous system, for which
few therapeutic options exist. Surgical resection is the primary treatment for most gliomas; …

Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET)

A Bashir, S Mathilde Jacobsen… - Neuro …, 2019 - academic.oup.com
Background Diagnostic accuracy in previous studies of O-(2-[18F]-fluoroethyl)-L-tyrosine
(18F-FET) PET in patients with suspected recurrent glioma may be influenced by prolonged …

Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine

N Galldiks, V Dunkl, G Ceccon, C Tscherpel… - European journal of …, 2018 - Springer
Background The goal of this prospective study was to compare the value of both
conventional MRI and O-(2-18 F-fluoroethyl)-L-tyrosine (FET) PET for response evaluation in …

Inhibiting astrocyte connexin‐43 hemichannels blocks radiation‐induced vesicular VEGF‐A release and blood–brain barrier dysfunction

S Schumacher, H Tahiri, P Ezan, N Rouach… - Glia, 2024 - Wiley Online Library
Therapeutic brain irradiation with ionizing radiation exerts multiple side effects including
barrier leakage that disturbs glial‐neuronal functioning and may affect cognition. Astrocytes …

Diagnostic and Prognostic Potential of 18F-FET PET in the Differential Diagnosis of Glioma Recurrence and Treatment-Induced Changes After Chemoradiation …

M Celli, P Caroli, E Amadori, D Arpa, L Gurrieri… - Frontiers in …, 2021 - frontiersin.org
Background MRI-based differential diagnosis of glioma recurrence (GR) and treatment-
induced changes (TICs) remain elusive in up to 30% of treated glioma patients. We aimed to …

[HTML][HTML] The emerging role of amino acid PET in neuro-oncology

AM Najjar, JM Johnson, D Schellingerhout - Bioengineering, 2018 - mdpi.com
Imaging plays a critical role in the management of the highly complex and widely diverse
central nervous system (CNS) malignancies in providing an accurate diagnosis, treatment …